Kyowa Kirin Co., Ltd. entered into a Transaction Agreement to acquire Orchard Therapeutics plc from RA Capital Management, L.P., Deep Track Capital, LP, Zentree Investment Management Pte. Ltd. and.
, collectively, the Closing Seller Preliminary Cash Consideration), minus 99.99% of the amount by which the Closing Seller Preliminary Cash Consideration exceeds $257,200,000 ; plus .